Raphas Co., Ltd. (KOSDAQ:214260)

South Korea · Delayed Price · Currency is KRW

7,080.00

+40.00 (0.57%)

At close: Nov 4, 2026

Market Cap	59.53B -43.9%
Revenue (ttm)	30.16B +4.6%
Net Income	-5.48B
EPS	-615.00
Shares Out	8.41M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,730
Open	7,110.00
Previous Close	7,040.00
Day's Range	6,920.00 - 7,260.00
52-Week Range	6,240.00 - 16,670.00
Beta	0.53
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Raphas

Raphas Co., Ltd. manufactures and sells biodegradable microneedles in Korea. The company offers skin care, medical device, whitening care, and wrinkle care under the Acropass brand; and health food product under the FitKong brand. It also supplies double-layer microneedle manufacturing technology; and provides original development manufacturing, and contract development and manufacturing organization services. The company was incorporated in 2006 and is based in Seoul, South Korea. [Read more]

Industry Perfumes, Cosmetics, and Other Toilet Preparations

Founded 2006

Employees 80

Stock Exchange KOSDAQ

Ticker Symbol 214260

Full Company Profile

Financial Performance

In 2025, Raphas's revenue was 30.99 billion, an increase of 13.86% compared to the previous year's 27.22 billion. Losses were -4.31 billion, -9.58% less than in 2024.

Financial Statements